Age-related macular degeneration. (Photo credit: Community Eye Health)
Scientists at Trinity College, Dublin say they have made a major breakthrough in treatment for age-related macular degeneration (AMD) – the leading cause of blindness in people over 50.
Through their research, they have discovered that interleukin-18 (IL-18), a component of the immune system, can protect patients from vision loss, and it can be administered in a non-invasive way. Since current treatments for AMD involve periodically injecting medication directly into the eyeball, this could have significant implications for AMD therapy.
“[IL-18] has already entered into clinical trials [for cancer research], and it has a very good safety profile when administered intravenously. It was never injected into the eye,” study author Matthew Campbell, research assistant professor in genetics at Trinity, told FoxNews.com.
“So all the signs show this could be another tool in the arsenal against wet AMD.”
AMD has two major forms: “dry,” the more common form, and “wet,” which accounts for 90 percent of the severe vision loss caused by macular degeneration. When a patient suffers from wet AMD, the blood vessels grow into the retina, the layer of tissue lining the inner surface of the eye, and begin to leak blood or fluid – causing immediate retinal blindness. Retinal blindness can be especially challenging for patients, as the retina provides sharp, central vision for reading, driving and perceiving small details.
In order to combat wet AMD, patients m? patients must receive them on a monthly basis.
Campbell and his team say IL-18 can work just as effectively as these anti-VEGF injections, as it produces cells that prevent wet AMD.
The Latest on: Age-related macular degeneration
[google_news title=”” keyword=”Age-related macular degeneration” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Age-related macular degeneration
- Neovascular Age-Related Macular Degenerationon September 19, 2023 at 4:59 pm
Choroidal neovascularization is the primary cause of visual loss in patients with age-related macular degeneration. Current treatments, proven to offer a benefit for these patients through ...
- Neovascular Age-related Macular Degeneration and anti-VEGF Nonresponderson September 16, 2023 at 5:01 pm
Neovascular age-related macular degeneration is responsible for the overwhelming majority of vision loss in age-related macular degeneration. Not too long ago, the disease was poorly controlled ...
- Visual Function and Mortality in Age-related Macular Degenerationon September 13, 2023 at 7:45 pm
In this study, poor visual acuity and a declining ability to drive safely were associated with increased all-cause mortality among persons with age-related macular degeneration. Share on Facebook.
- Age-Related Macular Degeneration: Circulating Metabolites, Genetics, and Lifestyleon September 13, 2023 at 7:45 pm
Cataract surgery significantly improves both distance and near vision in patients with neovascular age-related macular degeneration undergoing anti-vascular endothelial growth factor treatment ...
- Complement C3 Variant and the Risk of Age-Related Macular Degenerationon September 13, 2023 at 5:01 pm
Age-related macular degeneration is the most common cause of blindness in Western populations. Susceptibility is influenced by age and by genetic and environmental factors. Complement activation ...
- From hagfish to membrane: Modeling age-related macular degenerationon September 13, 2023 at 11:41 am
Researchers at Utah State University have successfully demonstrated that hagfish slime proteins can accurately replicate membranes in the human eye.
- Wet Age-Related Macular Degeneration Pipeline Insight Report 2023 (Updated)on September 12, 2023 at 2:30 pm
DelveInsight’s, “Wet Age-Related Macular Degeneration (Wet-AMD) Pipeline Insight, 2023,” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Wet Age-Related Macular ...
- Dry Age-Related Macular Degeneration Pipeline Insight 2023 (Updated)on September 12, 2023 at 2:30 pm
DelveInsight’s, “Dry Age-Related Macular Degeneration Pipeline Insight 2023” report provides comprehensive insights about 58+ companies and 64+ pipeline drugs in Dry Age-Related Macular ...
- Researchers discover new mechanism in the progression of age-related macular degenerationon September 12, 2023 at 8:48 am
Research led by Nicolas Bazan, MD, PhD, Boyd Professor, Ernest C. and Yvette C. Villere Chair for the Study of Retinal Degeneration, and Director of the Neuroscience Center of Excellence at LSU Health ...
- Can Machine Learning Detect Age-Related Macular Degeneration?on September 4, 2023 at 5:00 pm
A research team from National Cheng Kung University (NCKU), led by Chih-Chung Hsu, an assistant professor at the Institute of Data Science, NCKU, has demonstrated that machine learning can assist in ...
via Bing News
